HealthcareLife Sciences, Mental Health, Funding, Policy & Workforce,

Developing DMT based psychedelic therapies as clinical treatments: rationale, evidence, and regulatory challenges

02 Jun 2023Healthcare
Purchase access to view full content
Developing DMT based psychedelic therapies as clinical treatments: rationale, evidence, and regulatory challenges

Developing DMT based psychedelic therapies as clinical treatments: rationale, evidence, and regulatory challenges

02 Jun 2023Healthcare
About the speaker
Daniel Perkins
Daniel PerkinsCo-Director at Psychae Institute in Melbourne